Evidence map›Paper›PMID 32722629›Full record

ReviewInternational journal of molecular sciences2020

HIV Associated Risk Factors for Ischemic Stroke and Future Perspectives.

Saifudeen Ismael, Mohammad Moshahid Khan, Prashant Kumar, Sunitha Kodidela, Golnoush Mirzahosseini, Santhosh Kumar, Tauheed Ishrat

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 6 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 6 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Occludin: a gatekeeper of brain Infection by HIV-1.Fluids and barriers of the CNS · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Saifudeen IsmaelDepartment of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0001-9976-0939
Mohammad Moshahid KhanDepartment of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0003-4679-294X
Prashant KumarDepartment of Pediatrics, University of Tennessee Health Science Center and Le Bonheur Children's Hospital, Memphis, TN 38163, USA.ORCID 0000-0003-1038-6149
Sunitha KodidelaDepartment of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0002-9385-5985
Golnoush MirzahosseiniDepartment of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.ORCID 0000-0001-7846-5674
Santhosh KumarDepartment of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Tauheed IshratDepartment of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
University of Tennessee Health Science Center · US

Funding

Monocytic and exosomal cytochrome P450s in smoking-mediated HIV-1 pathogenesisR01DA047178 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CORY, THEODORE, KUMAR, SANTOSH · 2018 to 2022
$1.7M
NIDA NIH HHS DA047178NIDA NIH HHS R01 DA047178NIH HHS R01-NS097800
6 · The paper itself

Abstract

Although retroviral therapy (ART) has changed the HIV infection from a fatal event to a chronic disease, treated HIV patients demonstrate high prevalence of HIV associated comorbidities including cardio/cerebrovascular diseases. The incidence of stroke in HIV infected subjects is three times higher than that of uninfected controls. Several clinical and postmortem studies have documented the higher incidence of ischemic stroke in HIV infected patients. The etiology of stroke in HIV infected patients remains unknown; however, several factors such as coagulopathies, opportunistic infections, vascular abnormalities, atherosclerosis and diabetes can contribute to the pathogenesis of stroke. In addition, chronic administration of ART contributes to the increased risk of stroke in HIV infected patients. Concurrently, experimental studies in murine model of ischemic stroke demonstrated that HIV infection worsens stroke outcome, increases blood brain barrier permeability and increases neuroinflammation. Additionally, residual HIV viral proteins, such as Trans-Activator of Transcription, glycoprotein 120 and Negative regulatory factor, contribute to the pathogenesis. This review presents comprehensive information detailing the risk factors contributing to ischemic stroke in HIV infected patients. It also outlines experimental evidence demonstrating the impact of HIV infection on stroke outcomes, in addition to possible novel therapeutic approaches to improve these outcomes.

Indexed as

Blood-Brain BarrierHIV InfectionsIschemic StrokeHIV-1HumansMaleRisk FactorsViral ProteinsViral Proteinsextracellular vesiclesglycoprotein-120HIVischemic stroketrans-activator of transcription

Identifiers

PMID32722629
PMCPMC7432359
OpenAlexW3045212462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.